HIST1H2BB and MAGI2 methylation and somatic mutations in different samples are promising biomarkers for diagnosis and prognosis of high-grade serous ovarian cancer
Más información
| Título de la Revista: | CANCER PREVENTION RESEARCH |
| Editorial: | AMER ASSOC CANCER RESEARCH |
| Fecha de publicación: | 2020 |